In the next part of our ongoing collaboration, the team at RoukenBio take a look at a key decision point early in the lifecycle of a potency assay: what cells to choose. Potency assays rely on cells as their foundation, acting as essential tools for measuring biological activity and ensuring therapeutic efficacy. The choice of…
So, you’re confident that you’ve got a feasible assay with a well-defined dose-response curve. But bioassays, as we all know, are fickle. The observed responses are sensitive to many factors which can lead to appreciable variability in the experiment and, in turn, a high assay failure rate. An important part of the development phase of…
The bioassay development cycle can be a long and winding road, with vital decisions at every stage of the process. Choosing the wrong path can mean hours of wasted effort and vast amounts of unnecessary spending, while prudent choices can lead to an optimal assay, saving you time and money. That’s why we’ve teamed up…